Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2010-12-15. The firm operates in four business segments. The Medical Business segment produces and sells therapeutic drugs and infusions. The Nutraceutical segment produces and sells functional beverages, quasi-drugs and nutritional supplements. The Consumer Products segment produces and sells mineral water, beverages and food products. The Others segment manufactures paper containers, manufactures synthetic resin molded products, stores products, provides storage space, and produces and sells chemicals and liquid crystal evaluation equipment, spectroscopic analysis equipment, and other products.
Mr. Makoto Inoue 2020 'den beri şirketle birlikte olan Otsuka Holdings Co Ltd 'in President 'ıdır.
OTSUKA HLDGS CO LTD hissesinin fiyat performansı nasıl?
OTSUKA HLDGS CO LTD 'in mevcut fiyatı $69.59 'dir, son işlem günde 1.06% azalmış etti.
Otsuka Holdings Co Ltd için ana iş temaları veya sektörler nelerdir?
Otsuka Holdings Co Ltd Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Otsuka Holdings Co Ltd 'in piyasa değerlemesi nedir?
Otsuka Holdings Co Ltd 'in mevcut piyasa değerlemesi $37.7B 'dir
Otsuka Holdings Co Ltd al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 14 analist Otsuka Holdings Co Ltd için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 6 al, 5 tut, 0 sat ve 4 güçlü sat içermektedir